epm Therapeutics
Founded 2017
About epm Therapeutics
epm Therapeutics is a biotechnology company developing novel therapies to address unmet medical needs by researching the safety and efficacy of cannabinoid acid derivatives. These innovations represent novel treatment options for millions of patients worldwide covering a wide range of therapeutic conditions. Our current development focus is our EPM301 that has Orphan Drug (ODD) and Rare Pediatric Disease (RPD) designation by the USFDA and Orphan Drug in the EU for the treatment of hyperphagia (uncontrolled appetite) in Prader-Willi syndrome patients. For more information and where we are on our development timeline, please visit www.epmtherapeutics.com
Company Facts
- Founded: 2017
- Legal name: EPM Group, Inc
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Website: epmtherapeutics.com
- Phone: 859-487-9858
Social Profiles
Canonical: https://fsome.com/organization/epm-therapeutics-8429824 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.